Press release
Nucleic Acid Therapeutics Market is to Hit USD 12.09 billion in 2030 at a growth rate of 12.71% as per Maximize Market Research study
Nucleic Acid Therapeutics Market
Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/259289/
Nucleic Acid Therapeutics Market Report Scope and Research Methodology
Market Size in 2023: USD 5.23 Billion
Market Size in 2030: USD 12.09 Billion
CAGR: 12.71 Percent
Forecast Period: 2024-2030
Base Year: 2023
Number of Pages: 258
No. of Tables: 49
No. of Charts and Figures: 47
Segment Covered: By Type, Application, End-User and Region
Regional Scope: North America, Europe, Asia Pacific, Middle East and Africa, South America
Report Coverage: Market Share, Size and Forecast by Revenue | 2023-2030, Market Dynamics, Growth Drivers, Restraints, Investment Opportunities, and Key Trends, Competitive Landscape, Key Players Benchmarking, Competitive Analysis, SMR Competition Matrix, Competitive Leadership Mapping, Global Key Players' Market Ranking Analysis.
The Interested Stakeholders can Enquire for the Purchase of the Report : https://www.maximizemarketresearch.com/inquiry-before-buying/259289/
Nucleic Acid Therapeutics Market Overview
The nucleic acid therapeutics market is experiencing significant growth driven by the increasing prevalence of genetic disorders and chronic diseases. The market is segmented based on type, applications, and end-user. The Antisense oligonucleotides (ASOs) Segment held the largest share in 2023. Regionally, North America leads the nucleic acid therapeutics market, due to its strong focus on research and development and the presence of major pharmaceutical companies. The competitive landscape features key players such as Novartis Pharma AG, Agilent Technologies, and Nippon Shinyaku, all investing heavily in advancing nucleic acid-based therapies and expanding their global reach.
Nucleic Acid Therapeutics Market Dynamics
The Nucleic Acid Therapeutics market is driven by the rising prevalence of genetic disorders and chronic diseases such as cancer and neurodegenerative conditions. These therapies offer new solutions for diseases caused by genetic mutations, which traditional treatments often cannot address effectively. For example, Spinraza, an antisense oligonucleotide (ASO) therapy, has made significant strides in treating spinal muscular atrophy (SMA) by targeting faulty genes. As chronic and genetic diseases continue to rise, the demand for NATs is expected to grow. Future opportunities in the NAT market include advancements in targeting mRNA to prevent disease progression and expanding applications beyond rare diseases to more common conditions. However, challenges include the susceptibility of nucleic acids to degradation by cellular enzymes and difficulties in delivering these therapies to the right cells. Advanced technologies are needed to overcome these issues and ensure effective delivery.
Request Sample Copy of this Report @ https://www.maximizemarketresearch.com/request-sample/259289/
Nucleic Acid Therapeutics Market Segmentation
By Types
• Antisense oligonucleotides (ASOs)
• RNA interference (RNAi)
• Small interfering RNA (siRNA)
• Others
By Application
• Monogenetic disorders
• Multi-genetic disorders
By End User
• Hospitals and Clinics
• Academic and Research Institutes
• Others
Nucleic Acid Therapeutics Market's Key Players Include
• Novartis Pharma AG
• Ionis Pharmaceuticals, Inc.
• Arbutus Biopharma
• Thermo Fisher Scientific
• Agilent
• Alynylam Pharmaceuticals
• Nippon Shinyaku
• Silence Therapeutics plc
• Pfizer
• Sarepta Therapeutics
• Roche Holding AG
• Eli Lilly and Company
• Copernicus Therapeutics Inc.
• Sumitomo Chemical Co., Ltd.
• Aldevron
• Genzyme Sanofi
• lonis Pharmaceuticals, Inc.
• Moderna
𝐅𝐨𝐫 𝐚 𝐝𝐞𝐞𝐩𝐞𝐫 𝐮𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠, 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤: https://www.maximizemarketresearch.com/market-report/nucleic-acid-therapeutics-market/259289/
Key questions answered in the Nucleic Acid Therapeutics Market are:
• What is the demand pattern for the Nucleic Acid Therapeutics market?
• Which segment dominated the Nucleic Acid Therapeutics market growth?
• Who is the largest key player in the Nucleic Acid Therapeutics Market Growth?
• Which region held the largest share of the Nucleic Acid Therapeutics market?
• Who are the key players in the Nucleic Acid Therapeutics market?
• What is the growth rate of the Nucleic Acid Therapeutics Market?
• What are the factors expected to drive the Nucleic Acid Therapeutics market growth?
• What is the Nucleic Acid Therapeutics Market?
• What was the Nucleic Acid Therapeutics market size in 2023?
• What is the expected Nucleic Acid Therapeutics market size by 2030?
Key Offerings:
• Past Market Size and Competitive Landscape (2018 to 2022)
• Past Pricing and price curve by region (2018 to 2022)
• Market Size, Share, Size & Forecast by Different Segment | 2024-2030
• Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by Region
• Market Segmentation - A detailed analysis by Type, Application, End-User, and Region.
• Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
• PESTLE Analysis
• PORTER's analysis
• Value chain and supply chain analysis
Maximize Market Research is leading Healthcare Research Firm, has also published the following reports:
The Phytoestrogen Supplements Market size was valued at USD 3.21 Billion in 2023 and the total Phytoestrogen Supplements Market size is expected to grow at a CAGR of 5.66% from 2024 to 2030, reaching nearly USD 4.72 Billion by 2030.
Phytoestrogen Supplements Market : https://www.maximizemarketresearch.com/market-report/phytoestrogen-supplements-market/259141/
The Hyperuricemia Drugs Market size was valued at USD 5.08 Billion in 2023 and the total Hyperuricemia Drugs Market revenue is expected to grow at a CAGR of 8.52% from 2024 to 2030, reaching nearly USD 9.00 Billion by 2030.
Hyperuricemia Drugs Market : https://www.maximizemarketresearch.com/market-report/hyperuricemia-drugs-market/234607/
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical categories and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, category and demand analysis, and client impact studies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nucleic Acid Therapeutics Market is to Hit USD 12.09 billion in 2030 at a growth rate of 12.71% as per Maximize Market Research study here
News-ID: 3641678 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD
Ultrafiltered Milk Market Valued at USD 8.36 Billion in 2024, Anticipated to Gro …
The Ultrafiltered Milk Market size was valued at USD 8.36 Billion in 2024 and the total Ultrafiltered Milk revenue is expected to grow at a CAGR of 4.6% from 2025 to 2032, reaching nearly USD 11.99 Billion.
Ultrafiltered Milk Market Overview:
Ultrafiltered milk is gaining increasing attention in the dairy and functional food sectors thanks to its enhanced nutritional profile. Through a specialized membrane filtration process, ultrafiltration concentrates higher-molecular weight components…
Bath Towel Market to Grow from USD 10.46 Billion by 2032 at a CAGR of 6.7 %
The Bath Towel Market size reached USD 6.23 Bn in 2024 and is expected to reach USD 10.46 Bn by 2032, growing at a CAGR of 6.7 % during the forecast period.
Bath Towel Market Overview:
The bath towel industry is witnessing steady expansion, fueled by consumers' increasing focus on hygiene, comfort, and home aesthetics. High demand for plush, absorbent towels made of luxury materials such as Egyptian cotton, Turkish cotton,…
Carob Market to Reach USD 374.76 Million by 2032 Growing at a 5.3% CAGR
The global Carob Market was valued at USD 247.92 million in 2024 and is projected to reach USD 374.76 million by 2032, expanding at a compound annual growth rate (CAGR) of 5.3% during the forecast period from 2025 to 2032.
Carob Market Overview:
The carob market is experiencing significant growth, driven by its increasing popularity as a natural sweetener and plant-based alternative to chocolate. Derived from the seed pods of the carob…
Welding Electrode Market Expected To Reach USD 11.27 Bn by 2032
The Welding Electrode Market size was valued at USD 5.70 Billion in 2024 and the total Welding Electrode revenue is expected to grow at a CAGR of 8.9 % from 2025 to 2032, reaching nearly USD 11.27 Billion.
Welding Electrode Market Overview:
The Welding Electrode Market is evolving as a critical segment within the global manufacturing and construction industries. Welding electrodes are essential consumables that enable reliable and efficient joining of…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
